Wednesday, Jun 29, 2022
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Hyderabad | Suven Pharmaceuticals Csir Institutes Sign Mou For Manufacturing Anti Covid Drug
Ads

Suven Pharmaceuticals, CSIR institutes sign MoU for manufacturing anti-Covid drug

By Telangana Today
Published: Published Date - 05:51 PM, Thu - 10 June 21
The synthetic process know-how for Molnupiravir was sourced from CSIR-NIIST and scale up process was successfully carried out by CSIR-IICT The synthetic process know-how for Molnupiravir was sourced from CSIR-NIIST and scale up process was successfully carried out by CSIR-IICT

Hyderabad: Suven Pharmaceuticals Ltd, CSIR-Indian Institute of Chemical Technology, Hyderabad, and CSIR-National Institute of Interdisciplinary Science & Technology, Tiruvananthapuram, have entered into an MoU for the process technology transfer and manufacturing of the anti-Covid drug, Molnupiravir.

The antiviral drug was initially developed for the treatment of influenza and is repurposed to completely suppress the Covid virus transmission within 24 hours according to the study recently published in the Journal Nature Microbiology. The drug could be a game changer in mitigation of SARS-CoV-2 virus, a press release from IICT said.

The synthetic process know-how for Molnupiravir was sourced from CSIR-NIIST and scale up process was successfully carried out by CSIR-IICT. The complete technology know how will be transferred and SPL in turn will manufacture and launch in the market as an effective medication for Covid infected patients.

As per the agreement, CSIR IICT also would provide the process know-how for the manufacture of new anti-Covid drug 2-DG to treat moderately and severely Covid infected patients to reduce their oxygen dependency.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


 

  • Follow Us :
  • Tags
  • CSIR institutes
  • CSIR-IICT
  • CSIR-NIIST
  • IICT

Related News

  • Dr D Srinivasa Reddy takes charge as new Director of IICT

  • Hyderabad-based IICT scientists install water-from-air generating systems in Rishikesh, Tehdri districts

  • ‘India needs to prepare for future pandemics with smart investments’

  • Safety highest priority while developing adult Covid vaccination: Dr Krishna Ella

  • Hetero presents positive results from Molnupiravir phase III trials

  • Dr Reddy’s strengthening Covid portfolio

Latest News

  • Purushottam Gowda to play cross-dresser on EORTV’s ‘You Complete Me’

    4 mins ago
  • Google taking steps to exempt political emails from Gmail spam: Report

    6 mins ago
  • Prabhas completes 20 years in cinema

    9 mins ago
  • Udaipur tailor cremated, funeral procession amid tight security

    16 mins ago
  • Two-year-old Telugu kid wins netizens’ hearts and how!

    23 mins ago
  • Kajol, Suriya invited amongst others to become The Academy members

    26 mins ago
  • Jupiter CEO leaves $68 billion company to sit at the beach

    37 mins ago
  • 5 must-haves in your monsoon emergency bag

    38 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam